What is PRVB's gross margin?

Provention Bio (PRVB) has a gross margin of 95% and a net margin of -308%.

What is PRVB's P/E ratio?

Track Provention Bio (PRVB) P/E ratio, ROE, and valuation metrics over time.

Where can I see PRVB's full financials?

See Provention Bio (PRVB) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Provention Bio (PRVB) Financials — Revenue, Earnings, Cash Flow

$24.98

Last traded 2023-04-27 — delisted

NASDAQ · Healthcare · Biotechnology · $2.4B mcap · 70M float · 4.08% daily turnover

Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Dividends Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest Supply Chain

📊 Key Metrics

TTM

$13M

Revenue

+824.4% YoY

$-113M

Net Income

+1.3% YoY

$-76M

Free Cash Flow

+20.9% YoY

95.3%

Gross Margin

-371.5%

Op. Margin

-307.7%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE132.7%

ROA-60.7%

ROIC526.1%

Valuation

P/E-16.4

P/B15.3

EV/EBITDA-5.2

Leverage

Debt/Equity0.20

Current Ratio1.93

Interest Cov.-106.4x

Quality Scores

Piotroski F3/9

Altman Z0.45

Beneish M9.68